About: Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

AttributesValues
Author
Bibliographic Citation
  • Amiot Aurélien, Serrero Mélanie, Peyrin-Biroulet Laurent, Filippi Jérome, Pariente Benjamin, Roblin Xavier, Buisson Anthony, Stefanescu Carmen, Trang-Poisson Caroline, Altwegg Romain, Marteau Philippe, Vaysse Thibaud, Bourrier Anne, Nancey Stephane, Laharie David, Allez Matthieu, Savoye Guillaume, Moreau Jacques, Vuitton Lucine, Viennot Stephanie, Bouguen Guillaume, Abitbol Vered, Fumery Mathurin, Gagniere Charlotte, Bouhnik Yoram, GETAID Groupe d'Etude Thérapeutique des Affections. Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study. Alimentary Pharmacology & Therapeutics (Suppl), 2019, 50 (1), pp.40-53. ⟨10.1111/apt.15294⟩
Title
  • Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study
dc:date
  • 2019
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software